Nao Muraoka
Shizuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Extended Anticoagulation Therapy with Rivaroxaban for Cancer-Associated Low-Risk Pulmonary Embolism According to Status of Concomitant Deep Vein Thrombosis: Insights from the ONCO PE Randomized Trial.
Journal: Seminars in thrombosis and hemostasis
Published: August 14, 2026
Extended Rivaroxaban Therapy for Cancer-Associated Low-Risk Pulmonary Embolism by Chemotherapy Status: Insights from the ONCO PE Trial.
Journal: Thrombosis and haemostasis
Published: May 15, 2026
External validation of machine learning models predicting global longitudinal strain from conventional echocardiography in patients with cancer.
Journal: The international journal of cardiovascular imaging
Published: April 13, 2026
Extended Anticoagulation Therapy With Rivaroxaban for Cancer-Associated Low-Risk Pulmonary Embolism According to Different Performance Status Scores: Insights From the ONCO PE Randomized Trial.
Journal: Journal of the American Heart Association
Published: February 27, 2026
Number of thrombosed venous segments and clinical outcomes in cancer-associated isolated distal deep vein thrombosis: insights from the ONCO DVT Study.
Journal: Journal of thrombosis and thrombolysis
Published: February 02, 2026
Impact of body weight on clinical outcomes in cancer patients with low-risk pulmonary embolism receiving rivaroxaban: Insights from the ONCO PE trial.
Journal: Thrombosis research
Published: January 22, 2026
Real-World Safety and Effectiveness of Rivaroxaban in Cancer-Associated Venous Thromboembolism (PRIMECAST) - A Prospective Multicenter Study.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: December 03, 2025
Asymptomatic and symptomatic cardiac toxicity associated with immune checkpoint inhibitors: insights from a Japanese registry.
Journal: European heart journal open
Published: September 23, 2025
Long-Term Administration of Multikinase Inhibitors Is a Potential Risk Factor for Atherosclerosis in Patients with Thyroid Cancer.
Journal: Cardiology
Published: July 25, 2025
Extended anticoagulation therapy on clinical outcomes in patients with gastrointestinal cancer and isolated distal deep vein thrombosis: Insights from the ONCO DVT Study.
Journal: European journal of internal medicine
Published: May 22, 2025
The influence of metastasis on clinical outcomes in patients with cancer-associated isolated distal deep vein thrombosis: A pre-specified subgroup analysis from the ONCO DVT study.
Journal: Thrombosis research
Published: May 06, 2025
Last Updated: 09/26/2026